Antimicrobial Peptide Hydrogel Strategies Enhance Stability and Efficacy Against Multidrug-Resistant Bacteria
Background
The escalating crisis of multidrug-resistant bacterial infections necessitates novel therapeutic approaches beyond conventional antibiotics. Antimicrobial peptides (AMPs) offer a promising alternative due to their unique membrane-disrupting mechanism and low propensity for resistance development. However, their clinical utility is severely hampered by poor in vivo stability, short half-life, low bioavailability, and potential systemic toxicity. Effective delivery systems are crucial to unlock the full therapeutic potential of AMPs and address these critical limitations.
Study Design
This comprehensive review systematically outlines the design strategies for hydrogel-based delivery systems for antimicrobial peptides (AMPs). Researchers analyzed principles underlying the construction of various hydrogel types, including peptide-based, hybrid material, composite delivery systems, and stimulus-responsive hydrogels. The review specifically focused on how these diverse design strategies mitigate challenges associated with AMP delivery. Furthermore, it conducted an in-depth analysis of hydrogel characteristics and existing challenges through three key pathways: synergistic antimicrobial action, microenvironment regulation, and optimization of in vivo processes.
Results
Hydrogels, leveraging their three-dimensional network structure, effectively encapsulate, protect, and enable controlled release of AMPs, significantly enhancing their pharmacokinetic properties and therapeutic efficacy. The review highlights that diverse design strategies, such as peptide-based hydrogels and stimulus-responsive hydrogels, are critical for improving AMP stability and bioavailability. These systems can achieve synergistic antimicrobial action, modulate the local microenvironment to enhance efficacy, and optimize in vivo processes for sustained therapeutic effects. The analysis also underscores the immense potential of artificial intelligence (AI) in advancing the intelligent design and personalized treatment of AMP-containing hydrogels. > Hydrogel delivery systems are pivotal in overcoming the inherent limitations of AMPs, transforming them into viable candidates for combating multidrug-resistant pathogens by improving stability and controlled release.
Key Findings
- Hydrogels effectively encapsulate and protect AMPs, improving their stability, half-life, and bioavailability.
- Diverse hydrogel design strategies (peptide-based, hybrid, stimulus-responsive) are crucial for overcoming AMP delivery challenges.
- Hydrogels enhance AMP efficacy through synergistic antimicrobial action and
microenvironment regulation. - Artificial intelligence holds significant potential for intelligent design and personalized treatment with AMP-hydrogel systems.
- Clinical translation of AMP-hydrogel systems faces core challenges that require further research and development.
Why It Matters
This review provides a critical roadmap for developing next-generation AMP therapies, offering theoretical and practical guidance for researchers and biohackers. Optimizing AMP delivery via hydrogels could enable more stable, potent, and less toxic antimicrobial protocols, potentially expanding their use beyond topical applications to systemic infections. The insights into design strategies and microenvironment regulation suggest future protocols might involve tailored hydrogel formulations for specific infection types, improving efficacy and reducing dosing frequency. The integration of AI for intelligent design points towards a future where personalized AMP hydrogel treatments could become a reality, accelerating clinical translation and addressing the urgent need for new anti-infectives.
antimicrobial peptides
hydrogels
drug delivery
antimicrobial resistance
review
biomaterials